pubmed-article:2617649 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0237401 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0003320 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0006137 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0301872 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0036319 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0205146 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0205250 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0243130 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C1704788 | lld:lifeskim |
pubmed-article:2617649 | lifeskim:mentions | umls-concept:C0030523 | lld:lifeskim |
pubmed-article:2617649 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:2617649 | pubmed:dateCreated | 1990-3-1 | lld:pubmed |
pubmed-article:2617649 | pubmed:abstractText | Sera from individuals living in 2 areas endemic for Schistosoma mansoni in Minas Gerais, Brazil were assayed for the presence of antibodies against paramyosin and glutathione-S-transferase (GST), molecules previously implicated as vaccine immunogens from studies in laboratory hosts. A group was identified consisting of subjects who were stool-negative and had no record of previous infection but who were seropositive by enzyme-linked immunosorbent assay against crude adult worm antigen (SWAP). These individuals had anti-paramyosin antibody levels which were dramatically elevated with respect to those measured in infected (stool-positive) individuals living in the same endemic area. In contrast, the same 2 groups of stool-positive and stool-negative subjects could not be distinguished on the basis of their seroreactivity to either GST or SWAP. After chemotherapy, anti-paramyosin antibodies rose above pre-treatment levels and remained elevated in those individuals who became stool-negative. In contrast, anti-paramyosin antibodies decreased to pretreatment values in drug-treated individuals who failed to show complete parasitological cure. These results suggest that the immune response of humans to paramyosin may play a role in natural resistance to schistosome infection, and that an elevated antibody level against this antigen may be a useful correlate of drug-induced cure. | lld:pubmed |
pubmed-article:2617649 | pubmed:language | eng | lld:pubmed |
pubmed-article:2617649 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2617649 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2617649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2617649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2617649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2617649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2617649 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2617649 | pubmed:issn | 0035-9203 | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:KatzNN | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:SherAA | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:GazzinelliGG | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:CarvalhoO SOS | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:Correa-Olivei... | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:PearceE JEJ | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:OliveiraG CGC | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:GolgherD BDB | lld:pubmed |
pubmed-article:2617649 | pubmed:author | pubmed-author:BahiaL GLG | lld:pubmed |
pubmed-article:2617649 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2617649 | pubmed:volume | 83 | lld:pubmed |
pubmed-article:2617649 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2617649 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2617649 | pubmed:pagination | 798-804 | lld:pubmed |
pubmed-article:2617649 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:meshHeading | pubmed-meshheading:2617649-... | lld:pubmed |
pubmed-article:2617649 | pubmed:articleTitle | The human immune response to defined immunogens of Schistosoma mansoni: elevated antibody levels to paramyosin in stool-negative individuals from two endemic areas in Brazil. | lld:pubmed |
pubmed-article:2617649 | pubmed:affiliation | Centro de Pesquisas Rene Rachou, Fundaçao Oswaldo Cruz, Minas Gerais, Brazil. | lld:pubmed |
pubmed-article:2617649 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2617649 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:2617649 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2617649 | lld:pubmed |